| 1 |
28102631 | Cytochrome P450 isoform genotyping in poor propranolol responders for hemangioma treatment. | 2017 Jan |
1 |
| 2 |
12734935 | [Stereoselective determination of propranolol enantiomer in transgenic cell lines expressing human cytochrome P450]. | 2003 Apr |
3 |
| 3 |
7640150 | Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. | 1995 Apr |
2 |
| 4 |
7895609 | Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. | 1994 Nov-Dec |
2 |
| 5 |
2357863 | Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation. | 1990 Jun |
1 |
| 6 |
2910639 | Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. | 1989 Jan |
1 |
| 7 |
3128014 | Phenacetin O-deethylation by human liver microsomes: kinetics and propranolol inhibition. | 1988 Jan |
1 |
| 8 |
3111480 | Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidation. | 1987 Jul 15 |
6 |
| 9 |
7378257 | Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol. | 1980 Apr |
1 |
| 10 |
455885 | Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity. | 1979 Aug |
1 |